Skip to content

What is Nerisona cream and How Is It Used?

4 min read

Affecting 10% to 30% of children and 2% to 10% of adults, eczema is a common inflammatory skin disease. So, what is Nerisona cream? It's a potent topical corticosteroid used to manage such conditions by reducing inflammation, itching, and redness.

Quick Summary

Nerisona cream contains the active ingredient diflucortolone valerate, a potent topical corticosteroid. It works by suppressing inflammatory and allergic skin reactions, providing relief from symptoms like itching, burning, and pain.

Key Points

  • Active Ingredient: Nerisona's active ingredient is diflucortolone valerate, a potent topical corticosteroid.

  • Primary Use: It is used to treat inflammatory and allergic skin conditions like eczema, dermatitis, and psoriasis.

  • Mechanism: It works by suppressing the skin's inflammatory and allergic reactions, reducing redness, swelling, and itching.

  • Formulations: Available as cream for moist skin and fatty ointment for dry skin, with different strengths of diflucortolone valerate.

  • Short-Term Use: Treatment is typically short-term, not exceeding 3-4 weeks for adults to minimize risks.

  • Major Precautions: Should not be used on viral infections, rosacea, or acne, and used with caution on the face or in children.

  • Side Effects: Potential side effects include skin thinning, stretch marks, and with extensive use, systemic effects like adrenal suppression.

In This Article

Understanding Nerisona Cream

Nerisona is a topical medication primarily used in dermatology to treat various inflammatory and allergic skin conditions. Its active ingredient is diflucortolone valerate, which is classified as a potent (Class 3) topical corticosteroid. This means it is highly effective at reducing inflammation. The cream works by suppressing the body's inflammatory and immune responses in the skin, which in turn alleviates symptoms such as redness, swelling, itching, and pain associated with numerous skin ailments.

Nerisona is indicated for corticosteroid-responsive skin diseases, including eczema (dermatitis), psoriasis, lichen planus, and chronic discoid lupus erythematosus. It is designed for short-term use, typically with treatment for adults not exceeding three to four weeks.

Mechanism of Action

Diflucortolone valerate, the active component in Nerisona, functions by binding to glucocorticoid receptors within skin cells. This action initiates a process that alters gene expression, leading to two key outcomes:

  • Upregulation of anti-inflammatory proteins: The production of proteins that calm the inflammatory response, such as lipocortins, is increased.
  • Downregulation of pro-inflammatory mediators: The synthesis of substances that promote inflammation—like prostaglandins and cytokines—is reduced.

This dual-action approach effectively inhibits the migration of inflammatory cells to the affected area, reduces fluid leakage from capillaries (edema), and constricts blood vessels, thereby diminishing redness and swelling.

Formulations and Strengths

Nerisona is available in several formulations to suit different skin conditions. A cream is often prescribed for moist or weeping skin, while a fatty ointment is better for very dry skin or chronic conditions due to its occlusive properties that aid healing.

It typically comes in different strengths.

  • Nerisone: Contains a lower concentration of diflucortolone valerate and is considered a 'potent' topical steroid.
  • Nerisone Forte: Contains a higher concentration of diflucortolone valerate and is classified as a 'very potent' topical steroid, reserved for more severe flare-ups or conditions unresponsive to lower strengths.

Some formulations, like Nerisona C, may include an additional active ingredient to combat bacterial or fungal infections.

Feature Nerisone Nerisone Forte
Classification Potent Topical Corticosteroid Very Potent Topical Corticosteroid
Primary Use Moderate to severe inflammatory skin conditions Severe or resistant inflammatory skin conditions
Active Ingredient Lower concentration of Diflucortolone Valerate Higher concentration of Diflucortolone Valerate
Typical Duration Up to 3-4 weeks for adults Short-term, often 1-2 weeks

Proper Application

Proper application is crucial for maximizing effectiveness and minimizing risks. Nerisona should be applied as a thin film to the affected areas, as directed by a healthcare provider. Once the condition improves, the frequency is often reduced.

  • Treatment duration for adults should generally not exceed a few weeks.
  • For children, usage is more restrictive, often limited to shorter periods and on smaller surface areas, with increased caution due to higher absorption rates through their skin.
  • Application on the face should be avoided or limited to very short courses as the skin is more sensitive.
  • Occlusive dressings (airtight coverings) should only be used under medical advice, as they significantly increase the absorption of the corticosteroid into the bloodstream.

Potential Side Effects and Precautions

While effective, Nerisona can cause side effects, especially with prolonged use, application over large areas, or under occlusion.

Local Side Effects (More Common):

  • Burning, itching, or irritation at the application site
  • Skin thinning (atrophy)
  • Stretch marks (striae)
  • Acne-like eruptions
  • Changes in skin pigmentation
  • Excessive hair growth (hypertrichosis)

Systemic Side Effects (Less Common, from absorption into the bloodstream):

  • Adrenal suppression (the body reduces its own steroid production)
  • Cushing's syndrome (rounding of the face, weight gain)
  • Increased blood sugar
  • Glaucoma or cataracts if used near the eyes

Contraindications: Nerisone should not be used for certain conditions, including:

  • Viral skin infections (e.g., herpes, chickenpox)
  • Bacterial or fungal skin infections without appropriate antimicrobial treatment
  • Rosacea and perioral dermatitis (inflammation around the mouth)
  • Acne vulgaris
  • Allergy to diflucortolone valerate or other corticosteroids
  • On children under one year of age

Conclusion

Nerisona cream is a powerful and effective treatment for a range of inflammatory skin conditions when used correctly and under medical supervision. Its active ingredient, diflucortolone valerate, provides significant relief from symptoms like itching and redness. However, due to its potency, it must be used with caution. Adhering to the prescribed duration, understanding the potential side effects, and recognizing when not to use the cream are all essential for safe and effective treatment. Always consult a healthcare professional for diagnosis and before starting any new medication.


Disclaimer: This article is for informational purposes only and does not constitute medical advice. Always consult with a qualified healthcare professional for any health concerns or before making any decisions related to your health or treatment.

Patient.info on Diflucortolone

Frequently Asked Questions

Nerisona cream is used to treat a variety of corticosteroid-responsive skin diseases, such as eczema, dermatitis, psoriasis, and lichen planus. It helps to relieve symptoms like redness, swelling, and itching.

Using Nerisona on the face is generally not recommended, or should be limited to very short periods (e.g., 5 days) under a doctor's supervision. The skin on the face is more sensitive and prone to side effects like thinning.

Nerisone contains a lower concentration of the active ingredient diflucortolone valerate, while Nerisone Forte has a higher concentration. Nerisone Forte is considered 'very potent' and is used for more severe or resistant skin conditions.

For adults, treatment with Nerisona should typically not last longer than 3 to 4 weeks. Prolonged use increases the risk of side effects. For children, the duration is even shorter and should be strictly monitored by a doctor.

Common local side effects can include a burning sensation, itching, skin irritation, and dryness at the application site. With long-term use, more significant side effects like skin thinning (atrophy), stretch marks, and acne-like changes can occur.

Topical corticosteroids like Nerisona should generally be avoided during the first trimester of pregnancy. For the remainder of the pregnancy, it should only be used if the benefit outweighs the potential risk to the fetus, and application on large areas or for prolonged periods should be avoided.

Nerisona should not be used on skin affected by viral infections (like herpes or chickenpox), untreated bacterial or fungal infections, rosacea, acne, or perioral dermatitis. It is also contraindicated in patients with a known allergy to the ingredients.

References

  1. 1
  2. 2
  3. 3
  4. 4
  5. 5
  6. 6
  7. 7
  8. 8
  9. 9
  10. 10
  11. 11
  12. 12
  13. 13
  14. 14
  15. 15
  16. 16
  17. 17
  18. 18

Medical Disclaimer

This content is for informational purposes only and should not replace professional medical advice.